English

|Epaper|GadgetsNow

Videos

Top Searches:

Govt panel approves country's first indigenous vaccine for cervical cancer

Jun 16, 2022, 09:26AM ISTSource: Mirror Now

The DCGI subject expert committee has recommended Serum institute’s indigenously developed qHPV vaccine for cervical cancer patients.

03:22UP Demolition row: SC refuses to stop bulldozer drive in Prayagraj

01:17Congress leader Renuka Chowdhury holds cop's collar

03:20J&K: Govt orders Jamaat affliate Falah-e-Aam trust schools to shut

01:13Europe's biggest start-up conference recognizes India as 'country of the year' :Ashwini Vaishnaw

02:49Large number of Mongolians pay obeisance to Holy Kapilavastu Relics of Lord Buddha

01:34National Herald case twist - Rahul Gandhi reveals late leader's name

01:34Bengaluru Covid cluster: 31 students test positive in 2 private schools

05:37National Herald case: Rahul Gandhi summoned again on June 17

02:23Assam: Incessant rain triggers flood-like situation in Dima Hasao and Guwahati

02:15J&K HC accepts Kashmiri Pandits' plea to probe targeted killings

RelatedVideos

Covid-19: Covovax gets nod from drug regulator’s panel for emergency use in 12-17 yrs age group

Covid-19: Covovax gets nod from drug regulator’s panel for emergency use in 12-17 yrs age group

New Omicron detecting RT-PCR kit will give results in 4 hours: ICMR

New Omicron detecting RT-PCR kit will give results in 4 hours: ICMR

CDSCO panel clears Serum Institute's Covovax for emergency use; DCGI approval awaited

CDSCO panel clears Serum Institute's Covovax for emergency use; DCGI approval awaited

Subject Expert Committee recommends use of Covaxin for children between age group of 2-18

Subject Expert Committee recommends use of Covaxin for children between age group of 2-18

COVID: Phase 3 trial of Biological E underway

COVID: Phase 3 trial of Biological E underway

DCGI examining Zydus Cadila’s COVID vaccine for children: Dr VK Paul

DCGI examining Zydus Cadila’s COVID vaccine for children: Dr VK Paul

Zydus Cadila seeks emergency use nod for Covid vaccine, also tested in 12-18 year-olds

Zydus Cadila seeks emergency use nod for Covid vaccine, also tested in 12-18 year-olds

DCGI gives nod to import Moderna’s COVID vaccine for India

DCGI gives nod to import Moderna’s COVID vaccine for India

Covaxin trial for children begins in Patna's AIIMS

Covaxin trial for children begins in Patna's AIIMS

Covid-19: DCGI approves phase 2 & phase 3 clinical trials of Covaxin for age group of 2-18 years

Covid-19: DCGI approves phase 2 & phase 3 clinical trials of Covaxin for age group of 2-18 years

RelatedArticles

NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: Sources

NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: Sources

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

Covaxin a universal vaccine: BB; 10cr doses with govt: Bio E

Covaxin a universal vaccine: BB; 10cr doses with govt: Bio E

After DCGI nod, 37L kids await Cov jabs

After DCGI nod, 37L kids await Cov jabs

ZyCov-D gets EUA from DCGI as two-dose vax

ZyCov-D gets EUA from DCGI as two-dose vax

DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group

DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group

DCGI grants emergency use authorisation to Corbevax for those aged 5-12, Covaxin for 6-12 age group, ZycovD for above 12 year olds: Report

DCGI grants emergency use authorisation to Corbevax for those aged 5-12, Covaxin for 6-12 age group, ZycovD for above 12 year olds: Report

DCGI claims India on course to become global drugs hub

DCGI claims India on course to become global drugs hub

Novavax says its Covid vaccine gets India authorisation for adolescents

Novavax says its Covid vaccine gets India authorisation for adolescents

Phase 2,3 trial data of India's first mRNA Covid vaccine submitted to DCGI

Phase 2,3 trial data of India's first mRNA Covid vaccine submitted to DCGI

Get the app